-navir
An HIV protease inhibitor.
- Drugs ending in -navir: 12
- Approved somewhere: 10
- With a US drug page: 7
- Stem
- -navir
- Class
- Drugs that block HIV protease
- Sub-stem of
- vir: Antivirals
- Most common targets
- POL (12), Cytochrome P450 3A (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -navir, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Amprenavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Atazanavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Darunavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Fosamprenavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Nelfinavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Ritonavir | Approved | POL, Cytochrome P450 3A | Human immunodeficiency virus type 1 protease inhibitor |
| Tipranavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Indinavir anhydrous | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Lopinavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Saquinavir | Approved | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Brecanavir | Phase 2 | POL | Human immunodeficiency virus type 1 protease inhibitor |
| Telinavir | Phase 1 | POL | Human immunodeficiency virus type 1 protease inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO